Shockwave Medical Inc Revenue Growth Rates (SWAV), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Shockwave Medical Inc   (NASDAQ: SWAV)
 

SWAV's Revenue Growth by Quarter and Year

Shockwave Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SWAV Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 218.60
FY 218.60

SWAVs Annual Revenue
Shockwave Medical Inc 's Revenue in the fiscal year 2023 $ 729.84 millions
Shockwave Medical Inc 's Revenue in the fiscal year 2022 $ 489.73 millions
Shockwave Medical Inc 's Revenue in the fiscal year 2021 $ 237.15 millions
Shockwave Medical Inc 's Revenue in the fiscal year 2020 $ 67.79 millions
Shockwave Medical Inc 's Revenue in the fiscal year 2019 $ 42.93 millions




SWAV Revenue first quarter 2024 Y/Y Growth Comment
Shockwave Medical Inc reported Revenue improvement of 35.72% year on year in the first quarter 2024, to $ 218.60 millions, this is lower than Shockwave Medical Inc 's recent average Revenue surge of 152.76%.

Looking into first quarter 2024 results within Medical Equipment & Supplies industry 35 other companies have achieved higher Revenue growth. While Shockwave Medical Inc ' s Revenue rise of 35.72% ranks overall at the positon no. 498 in the first quarter 2024.


SWAV Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - 41.36 % 71.1 % 270.51 %
3rd Quarter September - 41.25 % 101.55 % 232.62 %
2nd Quarter June - 48.8 % 115.97 % 443.34 %
1st Quarter March 35.72 % 72.03 % 193.51 % 109.87 %
FY   - 49.03 % 106.51 % -

Financial Statements
Shockwave Medical Inc 's first quarter 2024 Revenue $ 218.60 millions SWAV's Income Statement
Shockwave Medical Inc 's first quarter 2023 Revenue $ 161.07 millions Quarterly SWAV's Income Statement


SWAV Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 9.75 % 9.67 % 29.19 %
3rd Quarter September - 3.25 % 8.76 % 16.54 %
2nd Quarter June - 11.55 % 28.97 % 75.27 %
1st Quarter March 7.37 % 11.83 % 11.23 % 40.4 %
FY (Year on Year)   - 49.03 % 106.51 % -


Back to SWAV Growth rate Comparisons >> Back to SWAV Growth rate Comparisons >>


Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #141
Overall #498

Revenue Y/Y Growth Statistics
High Average Low
449.85 % 152.76 % 2.74 %
(Jun 30 2021)   (Jun 30 2020)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #36
Healthcare Sector #141
Overall #498
Revenue Y/Y Growth Statistics
High Average Low
449.85 % 152.76 % 2.74 %
(Jun 30 2021)   (Jun 30 2020)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Shockwave Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
90.45 % 21.06 % -32.32 %
(Sep 30 2020)  


SWAV's I. Quarter Q/Q Revenue Comment
Shockwave Medical Inc achieved in the I. Quarter 2024 below company average Revenue increase of 7.37% quarter on quarter, to $ 218.60 millions.

Within Medical Equipment & Supplies industry 42 other companies have achieved higher Revenue quarter on quarter growth. While Shockwave Medical Inc 's Revenue growth quarter on quarter, overall rank is 836.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #43
Healthcare Sector #149
Overall #836
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #43
Healthcare Sector #149
Overall #836
Revenue Q/Q Growth Statistics
High Average Low
90.45 % 21.06 % -32.32 %
(Sep 30 2020)  


SWAV's I. Quarter Q/Q Revenue Comment
Shockwave Medical Inc achieved in the I. Quarter 2024 below company average Revenue increase of 7.37% quarter on quarter, to $ 218.60 millions.

Within Medical Equipment & Supplies industry 42 other companies have achieved higher Revenue quarter on quarter growth. While Shockwave Medical Inc 's Revenue growth quarter on quarter, overall rank is 836.


Shockwave Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 787.37 $ 729.84 $ 670.27 $ 616.09 $ 557.17
Y / Y Revenue Growth (TTM) 41.32 % 49.03 % 55.92 % 69.39 % 86.42 %
Year on Year Revenue Growth Overall Ranking # 156 # 47 # 34 # 171 # 110
Seqeuential Revenue Change (TTM) 7.88 % 8.89 % 8.79 % 10.58 % 13.77 %
Seq. Revenue Growth (TTM) Overall Ranking # 1016 # 652 # 329 # 952 # 647


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2024 period, Shockwave Medical Inc 's cumulative twelve months Revenue were $ 787 millions, company would post below average annual Revenue growth of 13.77% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Shockwave Medical Inc 's Revenue growth from the 203.6% growth in Dec 31 2023.

In the Healthcare sector 52 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 47 to 156.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 73
Healthcare Sector # 53
Overall # 156

Revenue TTM Y/Y Growth Statistics
High Average Low
253.73 %
 122.2 %
41.32 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 73
Sector # 237
S&P 500 # 1016
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2024 period, Shockwave Medical Inc 's cumulative twelve months Revenue were $ 787 millions, company would post below average annual Revenue growth of 41.32% year on year, if the fiscal year would end at Mar 31 2024.
A slow-down in the Shockwave Medical Inc 's Revenue growth from the 203.6% growth in Dec 31 2023.

In the Healthcare sector 52 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 47 to 156.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 73
Healthcare Sector # 53
Overall # 156

Revenue TTM Y/Y Growth Statistics
High Average Low
253.73 %
122.2 %
41.32 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 73
Sector # 237
S&P 500 # 1016




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SWAV's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Uniqure N v 59.34%$ 59.343 millions
Atrium Therapeutics Inc 58.67%$ 58.665 millions
Alnylam Pharmaceuticals Inc 54.82%$ 54.823 millions
Kyntra Bio Inc 54.59%$ 54.592 millions
Sunshine Biopharma Inc 54.09%$ 54.086 millions
Sanuwave Health Inc 53.27%$ 53.272 millions
Xtant Medical Holdings Inc 52.16%$ 52.160 millions
Natera Inc 52.11%$ 52.112 millions
Eyepoint Inc 52.08%$ 52.076 millions
Intra cellular Therapies Inc 52.00%$ 52.001 millions
Prosomnus Inc 47.63%$ 47.632 millions
Aurinia Pharmaceuticals Inc 46.19%$ 46.191 millions
Agios Pharmaceuticals Inc 46.00%$ 45.998 millions
Hims and Hers Health Inc 45.78%$ 45.775 millions
Viskase Holdings inc 44.74%$ 44.743 millions
Genedx Holdings Corp 44.67%$ 44.674 millions
Astrotech Corp42.86%$ 42.857 millions
Adma Biologics Inc 42.51%$ 42.511 millions
Evolus Inc 42.21%$ 42.214 millions
Agilon Health Inc 41.21%$ 41.210 millions
Clearpoint Neuro Inc 40.60%$ 40.604 millions
Orthopediatrics Corp39.84%$ 39.844 millions
Theravance Biopharma inc 39.22%$ 39.224 millions
Corcept Therapeutics Inc38.95%$ 38.952 millions
Zai Lab Limited38.78%$ 38.779 millions
Qhslab Inc 38.49%$ 38.489 millions
Tela Bio Inc 38.28%$ 38.277 millions
Shockwave Medical Inc 35.72%$ 35.720 millions
Biocryst Pharmaceuticals Inc 34.87%$ 34.870 millions
Deciphera Pharmaceuticals Inc 34.55%$ 34.546 millions


About Shockwave Medical Inc Revenue Growth Rates (SWAV), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Shockwave Medical Inc (CIK 1642545).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001642545-24-000091
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Shockwave Medical Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.